CAMs & HEALTH SUPPLEMENTS
Symrise presents a
reliable alternative to natural CBD
With Canapure, Symrise is setting new standards in the synthetic production of CBD. This nature-identical and especially pure cannabidiol is produced according to the quality standards of GMP.
O
riginally launched at CPhI Worldwide in November 2019, Canapure by Symrise is suitable for the same applications as natural cannabidiol (CBD). This is thanks to a production method developed to deliver a natureidentical cannabinoid, which Symrise expects will revolutionise the pharmaceutical industry. With Canapure (cannabidiol), the pharmaceutical industry now has access to a nature-identical, synthetically produced CBD that is both a valuable active pharmaceutical
8
CANNABIS GROW TH // WWW.PHARMACOS.CO.ZA
ingredient and an intermediate product for the development of new substances. Scientific studies prove that the nature-identical active ingredient is identical to CBD derived from the cannabis plant. At the same time, the Symrise product achieves a purity level of 99.8%.
STUDY RESULTS CONFIRM MATCHING PROPERTIES Canapure is identical to natural CBD, which does not have psychoactive effects. It is said to have
